Prolonged mitotic arrest induced by Wee1 inhibition sensitizes breast cancer cells to paclitaxel.
Ontology highlight
ABSTRACT: Wee1 kinase is a crucial negative regulator of Cdk1/cyclin B1 activity and is required for normal entry into and exit from mitosis. Wee1 activity can be chemically inhibited by the small molecule MK-1775, which is currently being tested in phase I/II clinical trials in combination with other anti-cancer drugs. MK-1775 promotes cancer cells to bypass the cell-cycle checkpoints and prematurely enter mitosis. In our study, we show premature mitotic cells that arise from MK-1775 treatment exhibited centromere fragmentation, a morphological feature of mitotic catastrophe that is characterized by centromeres and kinetochore proteins that co-cluster away from the condensed chromosomes. In addition to stimulating early mitotic entry, MK-1775 treatment also delayed mitotic exit. Specifically, cells
SUBMITTER: Lewis CW
PROVIDER: S-EPMC5650293 | biostudies-literature | 2017 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA